HOX Therapeutics Appoints Karl Keegan as Chief Executive Officer

Developing Targeted Therapies With Potential Applicability Across Many Cancer Types GUILDFORD, England, November 13, 2018 -- (Healthcare Sales & Marketing Network) -- HOX Therapeutics, the private biotechnology company developing first-in-class, highly... Biopharmaceuticals, Oncology, Personnel HOX Therapeutics, HOX genes
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news